Agnico Eagle Mines Ltd (AEM) Stock Price Today
Aura AI Summary
Key Stats
- $95.48BMarket Cap
- 2,052,065Volume
- Basic MaterialsSector
- $252.1952W High
- $136.3452W Low
- 56 DaysTypical Hold Time
- $92.32BEnterprise Value
- 0.95%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Agnico Eagle Mines Ltd (AEM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Agnico Eagle Mines Ltd has traded between a low of $136.34 and a high of $252.19, highlighting its annual price range. Buy and sell Agnico Eagle Mines Ltd shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Agnico Eagle Mines Ltd
Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Most Recent News
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...

Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...

Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.